Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.


Clinical trials in pulmonary arterial hypertension (PAH) highlight the need for tailored, patient-centric strategies—but these principles apply across all therapeutic areas. This whitepaper explores the critical role of multidisciplinary collaboration among sponsors, investigators, coordinators, and PAH patients—alongside the transformative impact of Clinical Trial Educators (CTEs).
Learn how IQVIA’s proven approach delivers “white glove” support for complex indications and can be adapted to any study setting.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.